GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EyeGene Inc (XKRX:185490) » Definitions » Total Assets

EyeGene (XKRX:185490) Total Assets : ₩67,776 Mil (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is EyeGene Total Assets?

EyeGene's Total Assets for the quarter that ended in Sep. 2024 was ₩67,776 Mil.

During the past 12 months, EyeGene's average Total Assets Growth Rate was 32.50% per year. During the past 3 years, the average Total Assets Growth Rate was 23.50% per year. During the past 5 years, the average Total Assets Growth Rate was 28.10% per year. During the past 10 years, the average Total Assets Growth Rate was 44.60% per year.

During the past 12 years, EyeGene's highest 3-Year average Total Assets Growth Rate was 126.40%. The lowest was 11.30%. And the median was 27.90%.

Total Assets is connected with ROA %. EyeGene's annualized ROA % for the quarter that ended in Sep. 2024 was -19.23%. Total Assets is also linked to Revenue through Asset Turnover. EyeGene's Asset Turnover for the quarter that ended in Sep. 2024 was 0.01.


EyeGene Total Assets Historical Data

The historical data trend for EyeGene's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EyeGene Total Assets Chart

EyeGene Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47,309.38 44,427.03 104,991.15 80,381.23 78,102.74

EyeGene Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 70,006.82 78,102.74 71,740.09 69,572.41 67,776.47

EyeGene Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

EyeGene's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=64334.047+13768.697
=78,103

EyeGene's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets=Total Equity (Q: Sep. 2024 )+Total Liabilities (Q: Sep. 2024 )
=53401.019+14375.455
=67,776

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EyeGene  (XKRX:185490) Total Assets Explanation

Total Assets is connected with ROA %.

EyeGene's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=-13208.788/( (69572.407+67776.474)/ 2 )
=-13208.788/68674.4405
=-19.23 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

EyeGene's Asset Turnover for the quarter that ended in Sep. 2024 is

Asset Turnover
=Revenue (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=959.961/( (69572.407+67776.474)/ 2 )
=959.961/68674.4405
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

EyeGene Total Assets Related Terms

Thank you for viewing the detailed overview of EyeGene's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


EyeGene Business Description

Traded in Other Exchanges
N/A
Address
Gangseo-gu, Seoul 401, B-dong 910 Gayang-dong, Seoul, KOR, 07528
EyeGene Inc is a South Korea based bio-venture company. It researches and develops biopharmaceuticals. Its products include EG-Mirotin, EG-HPV, EGVac systems. It provides drugs for the treatment of age-related degenerative diseases. Its products target diabetic retinopathy.

EyeGene Headlines

No Headlines